The clinical trial landscape continues to evolve as scientific breakthroughs and technological innovations emerge. Examine the state of Phase I–III clinical trials initiated in 2019 when you download the Annual Clinical Trials Roundup from Citeline’s Trialtrove, your trusted source for global clinical trials intelligence.
Join our panel of experts as they discuss the impact of COVID-19 on clinical trials, the new normal and future pathways to get ahead. Get the latest insights and status on recent clinical trials, the emergence of virtual trials, and what you need to know for success.
Gain Clarity of Sight into What Comes Next with Citeline According to Informa’s Pharmaprojects, less than 3% of all rare congenital and genetic diseases have an approved therapy. Opportunities abound if you know the risks. Make better strategic and planning decisions with Intelligence services that give you a clear line of sight, helping you maximize clinical and commercial opportunities, navigate uncertainties, and ensure more successful outcomes.
Listen to our podcast “The Future of Clinical Trials From the Investigator Perspective” from earlier this year and register for our upcoming webinar to learn new developments
Get the big picture trends and key takeaways with Citeline’s infographic, 2019 Completed Trials: The Beat Goes on for Industry Sponsored Trial Activity. Using pivotal data from Sitetrove, Trialtrove and Pharmaprojects, our graphic analysis covers the major industry clinical developments as only Citeline can.
Tap into expert analysis of the trends and what they mean for the future of pharma with Citeline’s latest whitepaper, 2019 Completed Trials: The Beat Goes on for Industry Sponsored Trial Activity.
Citeline, Datamonitor Healthcare: 医療用医薬品の市場調査レポート
This web event has now ended. You will be able to watch all sessions on demand soon. Register your interest now to receive an update when all sessions are available to view.
We conducted a survey to 100 clinical trial investigators to gauge expectations for future clinical research. Your free infographic provides key insight and analysis to help you understand the future clinical trial landscape.
Get a deeper understanding of breast cancer clinical trials initiated since 2014 and what the trends have meant for strategies in this area, with this free whitepaper from Citeline.
To increase flexibility and efficiency in drug development, master protocols have emerged as an innovative clinical trial design, including basket and umbrella trials. Learn more about how these approaches are being used within oncology research through an overview of the clinical landscape, trial outcomes and trends.
Pink Sheet: 世界の薬事規制と承認審査に関するニュース
Rising costs, patient recruitment issues, shifting regulations, and more are making bringing new drugs to market more difficult than ever. Explore changes in clinical trial design being adopted in response to these challenges with reporting from Pink Sheet.
KNect365 Life Sciences recently conducted a survey into the clinical trial industry at its most interesting point to date, as organisations are implementing new technologies and trends such as AI, virtual trials and wearables. The final report, based on 214 responses, reveals unique insights into what current benefits and challenges companies are facing in the processes of applying these new approaches to therapeutic development. Citeline introduces the report, exploring what some of the key takeaways mean for the industry.